Gracell Biotechnologies News

GRCLDelisted Stock  USD 4.02  0.26  6.07%   
About 61% of Gracell Biotechnologies' investor base is looking to short. The analysis of current outlook of investing in Gracell Biotechnologies suggests that many traders are alarmed regarding Gracell Biotechnologies' prospects. Gracell Biotechnologies' investing sentiment shows overall attitude of investors towards Gracell Biotechnologies.
  
over six months ago at benzinga.com         
SHAREHOLDER RIGHTS INVESTIGATION Halper Sadeh LLC Investigates HA, ICVX, PGTI, GRCL
benzinga news
over six months ago at finance.yahoo.com         
Gracell Biotechnologies Inc. Sponsored ADR is a Great Momentum Stock Should You Buy?
Yahoo News
over six months ago at zacks.com         
Gracell Biotechnologies Inc. Sponsored ADR is a Great Momentum Stock Should You Buy?
zacks News
over six months ago at news.google.com         
Should Biotechnology Stock Gracell Biotechnologies Inc Be in Your Portfolio Tuesday - InvestorsObser...
Google News at Macroaxis
over six months ago at talkmarkets.com         
Week In Review 1.7 Billion Collaboration Between Elpiscience And Astellas Is Final 2023 Deal
news
over six months ago at thelincolnianonline.com         
Gracell Biotechnologies Neutral Rating Reiterated at Piper Sandler
news
over six months ago at thelincolnianonline.com         
Gracell Biotechnologies Equal Weight Rating Reiterated at Wells Fargo Company
news
over six months ago at thelincolnianonline.com         
Gracell Biotechnologies Downgraded to Neutral at HC Wainwright
news
over six months ago at thelincolnianonline.com         
Gracell Biotechnologies Neutral Rating Reiterated at BTIG Research
news
over six months ago at news.google.com         
Is Gracell Biotechnologies Inc Stock a Good Value Thursday - InvestorsObserver
Google News at Macroaxis
over six months ago at thelincolnianonline.com         
Brokerages Set Gracell Biotechnologies Inc. Target Price at 13.67
news
over six months ago at zacks.com         
AstraZeneca Set to Acquire Gracell for 1.2 Billion
zacks News
over six months ago at finance.yahoo.com         
AstraZeneca Bolsters Cell Therapy Pipeline With Over 1B Deal For China-Based Gracell Biotechnologies
Yahoo News
over six months ago at marketwatch.com         
Gracell ADSs Take Flight Premarket on 1.2B Takeover by AstraZeneca
marketwatch News
over six months ago at benzinga.com         
AstraZeneca Bolsters Cell Therapy Pipeline With Over 1B Deal For China-Based Gracell Biotechnologies
benzinga news
Far too much social signal, news, headlines, and media speculation about Gracell Biotechnologies that are available to investors today. That information is available publicly through Gracell media outlets and privately through word of mouth or via Gracell internal channels. However, regardless of the origin, that massive amount of Gracell data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Gracell Biotechnologies news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Gracell Biotechnologies relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Gracell Biotechnologies' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Gracell Biotechnologies alpha.

Gracell Biotechnologies Performance against Dow Jones

 Price Growth (%)  
       Timeline  
Check out Risk vs Return Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.
You can also try the Investing Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.

Other Consideration for investing in Gracell Stock

If you are still planning to invest in Gracell Biotechnologies check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Gracell Biotechnologies' history and understand the potential risks before investing.
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Bonds Directory
Find actively traded corporate debentures issued by US companies